Stem cell therapy may help severe congestive heart failure

March 13, 2014, Medical College of Georgia
This is Dr. Adam Berman, electrophysiologist at the Medical College of Georgia at Georgia Regents University and Director of Cardiac Arrhythmia Ablation Services at Georgia Regents Health System. Credit: Phil Jones

Researchers want to know whether patients with debilitating heart failure can benefit by having their own stem cells injected into their ailing heart muscle.

The severe condition is ischemic dilated cardiomyopathy, a currently incurable condition resulting from significantly compromised blood flow to the as well as attacks, which leave the muscle bulky and inefficient and patients unable to carry out routine activities.

"We want to know if is an option for patients who have essentially run out of options," said Dr. Adam Berman, electrophysiologist at the Medical College of Georgia at Georgia Regents University and Director of Cardiac Arrhythmia Ablation Services at Georgia Regents Health System. "It's a very exciting potential therapy, and these studies are designed to see if it works to help these patients."

Berman is a Principal Investigator on the multi-site study in which stem cells are removed from the bone marrow, their numbers significantly increased by technology developed by Aastrom Biosciences, then injected into multiple weak points in the heart. At GR Health System, the procedure is performed in the Electrophysiology Lab where Berman threads a catheter into an artery from the groin into the heart. Three-dimensional maps of the heart are created to provide a clear picture of its natural geography as well as major sites of damage.

"Everyone's heart is different, their scar burden is different, everything is different," Berman said. From that vantage point, small needles - similar in size to those used for skin testing - are used to make about 12 to 20 strategic injections of , which can differentiate into a variety of cell types. In this case, researchers hope the cells will improve blood flow and function of the heart.

This video shows the stem cell procedure. Credit: Tim Johnson

Half of the study participants receive the stem cell treatment called ixmyelocel-T and the remainder a saline placebo. Patients go home the next day but researchers follow all participants for 12 months to assess heart function and quality of life. GR Health System plans to enroll a handful of patients in the clinical trial.

Treatment options for heart failure include frontline therapies such as diuretics to more extreme measures such as implantable ventricular assist devices and heart transplants.

Patients eligible for this trial have explored existing options and must have an internal defibrillator, a standard of care in these patients to help avoid sudden death from an . Sudden death and progressive heart muscle failure cause most congestive heart failure deaths. Before enrollment, a cardiothoracic surgeon and interventional cardiologist rule out other options to open the patient's coronary arteries.

While much work remains, Berman hopes stem cell therapy may one day be a part of early intervention to help keep from progressing to an advanced, debilitating state. "We hope this is the future," he said.

Laboratory studies at MCG and elsewhere indicate that stem cells injected into the heart typically survive only a week or two. "That has been a very debated point," said Dr. Neal Weintraub, cardiologist and Associate Director of MCG's Vascular Biology Center. So while evidence is limited that many stem cells actually turn into new heart cells, good evidence exists that they can help generate new blood vessels to reperfuse the heart and secrete factors that aid survival of existing heart cells, Weintraub said.

The sometimes dramatic change researchers see after injecting stem cells into the heart, at least in the laboratory, likely results from a combination of new and saved tissue, he said.

"What they do is produce a lot of factors that change the environment dramatically and conduce the normal cells in the tissue to work better and potentially help them survive," Weintraub said. His laboratory studies stem cells endogenous to the heart to learn more about how they work normally and how, in the future, they might be used therapeutically.

"If we can unlock the secrets, we might be able to teach the cells to do this repair on their own," Weintraub said. In fact, stem cells are found throughout the body, and while evidence suggests they already try to help repair damage, many patients have multiple related conditions, such as high blood pressure and diabetes, that prevent endogenous from working as well as they should, said Weintraub, who is a Co-Investigator on the new clinical study.

Unlike most clinical trials, Berman notes that if this study results are positive, participants who received placebo can also get ixmyelocel-T.

Explore further: Therapy using stem cells, bone marrow cells, appears safe for patients with ischemic cardiomyopathy

Related Stories

Therapy using stem cells, bone marrow cells, appears safe for patients with ischemic cardiomyopathy

November 18, 2013
Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection (TESI) with autologous mesenchymal stem cells and ...

UCLA doctors test stem-cell therapy to improve blood flow in angina patients

November 13, 2013
Marty Greenfield lives with crushing pain every day due to angina, a condition that is caused by an inadequate supply of blood to the heart. He has suffered a heart attack, and a coronary bypass procedure and angioplasty ...

Stem cells boost heart's natural repair mechanisms

January 30, 2013
Injecting specialized cardiac stem cells into a patient's heart rebuilds healthy tissue after a heart attack, but where do the new cells come from and how are they transformed into functional muscle?

Heart's own stem cells offer hope for new treatment of heart failure

August 15, 2013
Researchers at King's College London have for the first time highlighted the natural regenerative capacity of a group of stem cells that reside in the heart. This new study shows that these cells are responsible for repairing ...

Does cell therapy treatment prolong the lives of heart attack patients?

February 28, 2014
One of the world's largest clinical cell therapy trials has begun to enroll 3,000 heart attack patients, some of whom will have bone marrow cells extracted with a needle from their hip and fed into their heart using a catheter ...

Mayo Clinic restores disrupted heartbeat with regenerative intervention

September 3, 2013
Mayo Clinic researchers have found a way to resynchronize cardiac motion following a heart attack using stem cells. Scientists implanted engineered stem cells, also known as induced pluripotent stem (iPS) cells, into damaged ...

Recommended for you

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.